2018中国类风湿关节炎诊疗指南

2018-04-05 中华医学会风湿病学分会 中华内科杂志,2018,57(4):242-251.

类风湿关节炎(RA)是一种以侵蚀性关节炎为主要临床表现的自身免疫病,可发生于任何年龄。制订和实施符合我国国情的RA临床指南,对提高RA诊疗相关医师(风湿科、骨科、内科等),特别是县级与基层医疗机构医师正确诊断和治疗RA的能力,加强患者教育,提高我国RA诊疗水平将起到至关重要的作用。鉴于此,中华医学会风湿病学分会按照循证临床实践指南制订的方法和步骤,基于当前的最佳证据,结合临床医师的经验,考虑我国患

中文标题:

2018中国类风湿关节炎诊疗指南

发布日期:

2018-04-05

简要介绍:

类风湿关节炎(RA)是一种以侵蚀性关节炎为主要临床表现的自身免疫病,可发生于任何年龄。制订和实施符合我国国情的RA临床指南,对提高RA诊疗相关医师(风湿科、骨科、内科等),特别是县级与基层医疗机构医师正确诊断和治疗RA的能力,加强患者教育,提高我国RA诊疗水平将起到至关重要的作用。鉴于此,中华医学会风湿病学分会按照循证临床实践指南制订的方法和步骤,基于当前的最佳证据,结合临床医师的经验,考虑我国患者的偏好与价值观,平衡干预措施的利与弊,制订了"2018中国类风湿关节炎诊疗指南"。

 

拓展指南:类风湿相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1074413, encodeId=c8c110e441324, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bf5534402, createdName=玉豹豹, createdTime=Sat Nov 27 08:17:55 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001070, encodeId=06ff10010e010, content=很有意义的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Jul 20 10:07:19 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970154, encodeId=73029e0154ac, content=太需要了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/5d583f3d82c24a9eaf54d5dc32c830ff/82c82ea9e3d7428db2a20c25359482ab.jpg, createdBy=50b92213526, createdName=AlizaYu, createdTime=Tue Jun 01 20:06:21 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967518, encodeId=4b9f96e5183a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Fri May 21 16:17:18 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378793, encodeId=20c83e879369, content=托法替尼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Sat Feb 01 21:08:40 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2021-11-27 玉豹豹

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1074413, encodeId=c8c110e441324, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bf5534402, createdName=玉豹豹, createdTime=Sat Nov 27 08:17:55 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001070, encodeId=06ff10010e010, content=很有意义的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Jul 20 10:07:19 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970154, encodeId=73029e0154ac, content=太需要了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/5d583f3d82c24a9eaf54d5dc32c830ff/82c82ea9e3d7428db2a20c25359482ab.jpg, createdBy=50b92213526, createdName=AlizaYu, createdTime=Tue Jun 01 20:06:21 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967518, encodeId=4b9f96e5183a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Fri May 21 16:17:18 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378793, encodeId=20c83e879369, content=托法替尼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Sat Feb 01 21:08:40 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2021-07-20 ms1000000861491970

    很有意义的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1074413, encodeId=c8c110e441324, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bf5534402, createdName=玉豹豹, createdTime=Sat Nov 27 08:17:55 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001070, encodeId=06ff10010e010, content=很有意义的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Jul 20 10:07:19 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970154, encodeId=73029e0154ac, content=太需要了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/5d583f3d82c24a9eaf54d5dc32c830ff/82c82ea9e3d7428db2a20c25359482ab.jpg, createdBy=50b92213526, createdName=AlizaYu, createdTime=Tue Jun 01 20:06:21 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967518, encodeId=4b9f96e5183a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Fri May 21 16:17:18 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378793, encodeId=20c83e879369, content=托法替尼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Sat Feb 01 21:08:40 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2021-06-01 AlizaYu

    太需要了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1074413, encodeId=c8c110e441324, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bf5534402, createdName=玉豹豹, createdTime=Sat Nov 27 08:17:55 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001070, encodeId=06ff10010e010, content=很有意义的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Jul 20 10:07:19 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970154, encodeId=73029e0154ac, content=太需要了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/5d583f3d82c24a9eaf54d5dc32c830ff/82c82ea9e3d7428db2a20c25359482ab.jpg, createdBy=50b92213526, createdName=AlizaYu, createdTime=Tue Jun 01 20:06:21 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967518, encodeId=4b9f96e5183a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Fri May 21 16:17:18 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378793, encodeId=20c83e879369, content=托法替尼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Sat Feb 01 21:08:40 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2021-05-21 pqssy

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1074413, encodeId=c8c110e441324, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bf5534402, createdName=玉豹豹, createdTime=Sat Nov 27 08:17:55 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001070, encodeId=06ff10010e010, content=很有意义的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Tue Jul 20 10:07:19 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970154, encodeId=73029e0154ac, content=太需要了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/5d583f3d82c24a9eaf54d5dc32c830ff/82c82ea9e3d7428db2a20c25359482ab.jpg, createdBy=50b92213526, createdName=AlizaYu, createdTime=Tue Jun 01 20:06:21 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967518, encodeId=4b9f96e5183a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Fri May 21 16:17:18 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378793, encodeId=20c83e879369, content=托法替尼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Sat Feb 01 21:08:40 CST 2020, time=2020-02-01, status=1, ipAttribution=)]
    2020-02-01 14825a3cm79暂无昵称

    托法替尼

    0